ABOUT CAM

25 years experience as an executive in the global cannabis and biopharmaceutical industries.
Former equity partner, strategic advisor and director of medical cannabis company MedReleaf Australia from 2019 until its sale to Aurora Cannabis in 2024.
Previously served as senior vp, executive vp, then chief corporate officer for Aurora, as well as in executive roles for Canopy Growth Corporation and Bedrocan Canada.
Previously elected a member of the board of directors of the Canadian Medical Cannabis Industry Association (later Cannabis Council of Canada).
Started pharmaceutical career with Eli Lilly, and later founded Health Strategy Group Inc., a management consultancy working with leading health care companies in North America, Europe, Asia and Africa, as well as the World Medical Association.
He has been a director of the patient advocacy group Campaigning for Cancer (South Africa) since 2007.